CliffBio
small molecule

KYZATREX

TESTOSTERONE UNDECANOATE

Loss of exclusivity—loss of exclusivity
CompanyMARIUS PHARMACEUTICALS INC

Drug detail

Brand nameKYZATREX
Active ingredientTESTOSTERONE UNDECANOATE
Strength50MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2026
Marketing statusRX

More from MARIUS PHARMACEUTICALS INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.